Loading clinical trials...
Loading clinical trials...
Validation of MMS Test to Detect Active Tumor Growth of Different Cancer Types Before and After Therapy, as Well as for Subsequent Relapse Control in Comparison to Conventional Methods
The purpose of this study is the validation of MMS test to detect active tumor growth in different cancer types before and after therapy, as well as in the course of therapy and for subsequent relapse control compared to standard methods (clinical examination, imaging, tumor markers). It should be consider whether the MMS test has comparable diagnostic accuracy, and thus can replace more expensive or invasive procedures in future.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
HELIOS Klinikum Berlin-Buch, Klinik für Interdisziplinäre Onkologie
Berlin, Germany
Start Date
May 1, 2014
Primary Completion Date
June 20, 2018
Completion Date
June 20, 2018
Last Updated
June 21, 2018
100
ACTUAL participants
Lead Sponsor
MedInnovation GmbH
Collaborators
NCT05039801
NCT06066138
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions